Patients with atrial fibrillation (AF) have a substantial risk of stroke and thromboembolism
compared with age-matched people in sinus rhythm, which varies with associated …

Background Atrial fibrillation is associated with stroke, yet approximately 50% of patients are
not treated with guideline-directed oral anticoagulants (OACs). Aims Given that the etiology …

Background Among patients with nonvalvular atrial fibrillation (AF) and an elevated stroke
risk, guidelines recommend direct oral anticoagulants (DOACs) over warfarin for stroke …

OBJECTIVE: To review the clinical trials evaluating warfarin for primary stroke prophylaxis in
nonvalvular atrial fibrillation (NVAF), to discuss the relative benefits and risks of warfarin …

Objective To investigate the impact on outcomes of changing treatment guideline
recommendations by comparing the proportion of patients with atrial fibrillation (AF) …

Atrial fibrillation (AF) is a global health problem. The condition brings an increased risk of
stroke, systemic embolism, and heart failure (HF) and is associated with impaired quality of …

Oral anticoagulation (OAC) with warfarin is highly beneficial, but such therapy is
inconvenient and carries a risk of bleeding. Thus, stroke risk stratification schemes have …

Background The prevalence of atrial fibrillation (AF) is substantial and increasing. Stroke is
common in AF and can have devastating consequences. Oral anticoagulants are effective in …

Atrial fibrillation (AF) causes 1 in 7 strokes as it is the most prevalent arrhythmia in the United
States. 1 Previous work has shown that even with significant recurring AF and high …

This editorial refers to 'Non-vitamin K antagonist oral anticoagulants: considerations on once-
vs. twice-daily regimens and their potential impact on medication adherence'by B. Vrijens …